CLINICAL_TRIALS
trial_result
· 2019-03-28
Clinical Trial Update: TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study [NA]
Summary
Completed post-approval study evaluating TactiCath contact force ablation catheter for paroxysmal atrial fibrillation; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott Medical Devices | Conditions: Paroxysmal Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2019-03-28